Adaptive Cardiac Ablation System with Real-Time Tissue Characterization

An advanced cardiac ablation system that integrates real-time tissue characterization, machine learning algorithms, and dynamically adjustable treatment arrays to provide personalized and optimized ablation procedures.

The original semi-circular ablation catheter patent has limitations in terms of its fixed treatment array configuration and lack of real-time tissue feedback. The new inventive concept addresses these limitations by introducing a system that can adapt to individual patient needs and cardiac tissue properties, enabling more effective and efficient ablation procedures.

The system comprises a catheter assembly with a selectively configurable treatment array, a sensor suite for real-time monitoring of cardiac tissue properties, and a control unit for dynamically adjusting the treatment array configuration based on the monitored tissue properties. The system utilizes machine learning algorithms to create patient-specific cardiac models, identify optimal ablation patterns, and deliver energy to the identified patterns. The catheter assembly features a flexible shaft with a shape-memory alloy core, a plurality of electrodes, and a micro-actuator system for dynamically adjusting the shaft shape and electrode configuration during ablation procedures.

The new claims introduce a paradigm shift in cardiac ablation technology by integrating real-time tissue characterization, machine learning algorithms, and dynamically adjustable treatment arrays. This combination of features enables a new level of personalization and optimization in ablation procedures, which is not possible with the original semi-circular ablation catheter patent.

Alternative embodiments of the inventive concept could include the use of different sensor types, such as optical or electrical impedance sensors, or the integration of additional features, such as cardiac mapping or navigation systems. Variations of the system could be designed for specific cardiac arrhythmia types or patient populations, further expanding the potential applications of the technology.

The adaptive cardiac ablation system has significant commercial potential in the medical device industry, particularly in the fields of cardiac electrophysiology and interventional cardiology. The system's ability to provide personalized and optimized ablation procedures could lead to improved patient outcomes, reduced procedure times, and increased market share for companies that adopt this technology.